Quantitative detection of mutant alleles with minor groove binder-conjugated fluorogenic DNA probes

使用小沟结合剂缀合的荧光 DNA 探针定量检测突变等位基因

• 批准号: 16591347
• 负责人: OTSUKA Koki
• 金额: $ 2.3万
• 依托单位: Iwate medical University School of Medicine
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (C)
• 财政年份: 2004
• 资助国家: 日本
• 起止时间: 2004 至 2005
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-16591347/
• 关键词: k-ras; MGB; colorectal cancer; real-time PCR; p53; APC; 大腸癌

Tumor-specific point mutations are stable biomarkers compared with tumor-specific mRNA expression, and are therfore useful to detect occult tumor cells. These mutations have never been used for real-time quantitative polymerase chain reaction (RQ-PCR) assays, because the ability of conventional probes to discriminate between wild-type and mutant alleles is poor. Recently, DNA probes with conjugated minor groove binder (MGB) have been developed. Because of their high melting temperature, these probes achieve high performance in detecting single nucleotide mismatches. Using the MGB technology, we developed a new RQ-PCR system for detecting occult tumor cells in patients with colorectal cancer (CRC), targeting K-ras point mutations. Sixteen MGB-conjugated DNA probes were designed for all previously reported K-ras mutations. The performance of these probes was examined with plasmid DNAs into which K-ras point mutations had been inserted, 32 cancer cell lines and 338 lymph nodes obtained from 15 CRC patients. Fifteen of the 16 MGB probes designed were useful for accurate quantitative assessment, and achieved high sensitivity (1/10^4-10^5 background cells) and high reproducibility (coefficients of variation < 10%). Performance in discriminating single nucleotide mismatches was superior for MGB probes compared with non-MGB probes. We detected a micrometastasis (5.85/10^4 cells equivalent) in one (0.9%) of 110 lymph nodes obtained from 6 patients with K-ras mutations. There was no true false-positive result in 209 lymph nodes obtained from 9 patients without K-ras mutations. The MGB RQ-PCR assay targeting K-ras mutations is an accurate quantitative method for detecting occult tumor cells in CRC.

与肿瘤特异性mRNA表达相比，肿瘤特异性点突变是稳定的生物标志物，因此可用于检测隐匿性肿瘤细胞。这些突变从未用于实时定量聚合酶链反应（RQ-PCR）分析，因为传统探针区分野生型和突变型等位基因的能力很差。近年来，利用共轭小凹槽粘结剂（conjugated minor groove binder， MGB）的DNA探针得到了发展。由于它们的高熔融温度，这些探针在检测单核苷酸错配方面具有很高的性能。利用MGB技术，我们开发了一种新的RQ-PCR系统，用于检测结直肠癌（CRC）患者的隐性肿瘤细胞，靶向K-ras点突变。16个MGB-conjugated DNA探针被设计用于所有先前报道的K-ras突变。用插入K-ras点突变的质粒dna，从15例结直肠癌患者中获得32株癌细胞和338个淋巴结，检测了这些探针的性能。设计的16个MGB探针中有15个可用于准确的定量评估，具有高灵敏度（1/10^4-10^5个背景细胞）和高重复性（变异系数< 10%）。与非MGB探针相比，MGB探针鉴别单核苷酸错配的性能更好。我们在6例K-ras突变患者的110个淋巴结中检测到一个（0.9%）微转移（5.85/10^4细胞当量）。无K-ras突变的9例患者的209个淋巴结没有真正的假阳性结果。针对K-ras突变的MGB RQ-PCR检测是一种检测CRC隐匿性肿瘤细胞的准确定量方法。

项目成果

Biacore's SPR technology for the development of telomere/telomerase-targeted therapies

Biacore 的 SPR 技术用于开发端粒/端粒酶靶向疗法

• 发表时间: 2004
• 期刊: BIACORE JOURNAL 4(1)
• 作者: Kammori M;Onoda N;Nakamura K;Izumiyama N;Ogisawa K;Kurabayashi R;Ogawa T;Miura Y;Kaminishi M;Poon S;Takubo K;Ohsugi T--3名--Horie R--4名--Urano T.;Maesawa C
• 通讯作者: Maesawa C

Prognostic significance of peritoneal minimal residual disease in gastric cancer detected by reverse transcription-polymerase chain reaction

• DOI: 10.1002/bjs.4455
• 发表时间: 2004-04-01
• 期刊: BRITISH JOURNAL OF SURGERY
• 影响因子: 9.6
• 作者: Oyama, K;Terashima, M;Maesawa, C
• 通讯作者: Maesawa, C

Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with cholelithiasis.

胆囊上皮中异常的 maspin 表达与胆石症患者的肠化生有关。

• 发表时间: 2006
• 期刊: J Clin Pathol 59(3)
• 作者: Maesawa C;Ogasawara S;Yashima-Abo A;Kimura T;Kotani K;Masuda S;Nagata Y;Iwaya T;Suzuki K;Oyake T;Akiyama Y;Kawamura H;Masuda T.
• 通讯作者: Masuda T.

Consensus JH gene probes with conjugated 3'-minor groove binder for monitoring minimal residual disease in acute lymphoblastic leukemia.

具有缀合 3-小沟结合物的共有 JH 基因探针，用于监测急性淋巴细胞白血病的微小残留病。

• 发表时间: 2005
• 期刊: J Mol Diagn 7
• 作者: Uchiyama M;Maesawa C;Yashima-Abo A;Tarusawa M;Endo M;Sugawara W;Chida S;Onodera S;Tsukushi Y;Ishida Y;Tsuchiya S;Masuda T.
• 通讯作者: Masuda T.

Epigenetic status and aberrant expression of the maspin gene in human hepato-biliary tract carcinomas

• DOI: 10.1038/labinvest.3700214
• 发表时间: 2005-02
• 期刊: Laboratory Investigation
• 影响因子: 5
• 作者: K. Fujisawa;C. Maesawa;Ryo Sato;K. Wada;S. Ogasawara;Y. Akiyama;Masaru Takeda;T. Fujita;K. Otsuka;T. Higuchi;Kazuyuki Suzuki;K. Saito;T. Masuda